hsa-miR-214

ncRNA information

ncRNA name

hsa-miR-214

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

PTEN/AKT signaling pathway

Cancer information

Cancer name

Non-Small Cell Lung Cancer

Cancer site

Lung

Treatment information

Treatment type

Chemotherapy

Drug

Gefitinib

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Down

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Knockdown of miR-214 altered the expression of PTEN and p-AKT and re-sensitized HCC827/GR to gefitinib.

Tissue resource

human adenocarcinoma lung cancer cell lines HCC827

human embryonic kidney cell lines HEK-293T

Experiment

qRT-PCR,Western blot,Dual-luciferase reporter assay


Institute

American Type Culture Collection

Country

USA

Continent

Amercia